Apolipoprotein E in temporal lobe epilepsy: A case-control study

Disease Markers

Volumn 22, Issue 5-6, 2006, Pages 335-342

  Kumar, Amit ^a   Tripathi, Manjari ^a   Pandey, Ravindra M ^a   Ramakrishnan, Lakshmy ^a   Srinivas, M ^a   Luthra, Kalpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apolipoprotein E; Asian Indians; Gene polymorphism; Plasma apo E levels; Temporal lobe epilepsy

Indexed keywords

APOLIPOPROTEIN E; LIPID;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TEMPORAL LOBE EPILEPSY;

EID: 33847417131     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/951632     Document Type: Article

References (49)

1. R.W. Mahley and S.C. Rall, Jr., Apolipoprotein E: far more than a lipid transport protein, Annu Rev Genomics Hum Genet. 1 (2000), 507-537.
2. M. Buttini, M. Orth, S. Bellosta, H. Akeefe, R.E. Pitas, T. Wyss-Coray, L. Mucke and R.W. Mahley, Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration, J Neurosci. 19 (1999), 4867-4880.
3. K. Luthra, K. Prasad, P. Kumar, M. Dwivedi, R.M. Pandey and N. Das, Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study, Clin Genet. 62 (2002), 39-44.
4. K. Luthra, M. Tripathi, R. Grover, M. Dwivedi, A. Kumar and A.B. Dey, Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia, Dement Geriatr Cogn Disord. 17 (2004), 132-135.
5. M.J. Alberts, C. Graffagnino, C. McClenny, D. DeLong, W. Strittmatter, A.M. Saunders and A.D. Roses, ApoE genotype and survival from intracerebral haemorrhage, Lancet. 346 (1995), 575.
6. G.M. Teasdale, J.A. Nicoll, G. Murray and M. Fiddes, Association of apolipoprotein E polymorphism with outcome after head injury, Lancet. 350 (1997), 1069-1071.
7. G.K. Gouras, N.R. Relkin, D. Sweeney, D.G. Munoz, I.R. Mackenzie and S. Gandy, Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques, Ann Neurol. 41 (1997), 402-404.
8. J.G. Sheng, F.A. Boop, R.E. Mrak and W.S. Griffin, Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity, J Neurochem. 63 (1994), 1872-1879.
9. B.P. Nathan, S. Bellosta, D.A. Sanan, K.H. Weisgraber, R.W. Mahley and R.E. Pitas, Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro, Science. 264 (1994), 850-852.
10. M. Miyata and J.D. Smith, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides, Nat Genet. 14 (1996), 55-61.
11. Y. Christen, Oxidative stress and Alzheimer disease, Am J Clin Nutr. 71 (2000), 621S-629S.
12. J.S. Gong, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S.C. Fujita, K. Yanagisawa and M. Michikawa, Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice, J Biol Chem. 277 (2002), 29919-29926.
13. J.W. Sheng, Y.E. Hu and Z.Q. Xia, [Structure and biological activity of beta amyloid protein precursor], Sheng Li Ke Xue Jin Zhan. 31 (2000), 166-168.
14. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA 90 (1993), 1977-1981.
15. R.S. Briellmann, Y. Torn-Broers, B.E. Busuttil, B.J. Major, R.M. Kalnins, M. Olsen, G.D. Jackson, A.G. Frauman and S.F. Berkovic, APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy, Neurology. 55 (2000), 435-437.
16. E. Masliah, M. Mallory, I.Veinbergs, A. Miller andW. Samuel, Alterations in apolipoprotein E expression during aging and neurodegeneration, Prog Neurobiol. 50 (1996), 493-503.
17. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg and R.E. Rydel, beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J Neurosci. 12 (1992), 376-389.
18. R.W. Mahley, B.P. Nathan and R.E. Pitas, Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease, Ann N Y Acad Sci. 777 (1996), 139-145.
19. A.D. Roses, M.A. Pericak-Vance, A.M. Saunders, D. Schmechel, D. Goldgaber and W. Strittmatter, Complex genetic disease: can genetic strategies in Alzheimer's disease and new genetic mechanisms be applied to epilepsy? Epilepsia. 35(Suppl 1) (1994), S20-S28.
20. R. Diaz-Arrastia, Y. Gong, S. Fair, K.D. Scott, M.C. Garcia, M.C. Carlile, M.A. Agostini and P.C. Van Ness, Increased risk of late posttraumatic seizures associated with inheritance of APOE ε?4 allele, Arch Neurol. 60 (2003), 818-822.
21. S.N. Yeni, C. Ozkara, N. Buyru, O. Baykara, L. Hanoglu, N. Karaagac, E. Ozyurt and M. Uzan, Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis, Eur J Neurol. 12 (2005), 103-107.
22. G.L. Cavalleri, J.M. Lynch, C. Depondt, M.W. Burley, N.W. Wood, S.M. Sisodiya and D.B. Goldstein, Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain. 128 (2005), 1832-1840.
23. E.S. Kilpatrick, C.E. Jagger, R.J. Spooner and M.J. Brodie, Apolipoprotein E and epilepsy, Ann Clin Biochem. 33(Pt 2) (1996), 146-147.
24. I. Blumcke, A. Brockhaus, C. Scheiwe, B. Rollbrocker, H.K. Wolf, C.E. Elger and O.D. Wiestler, The apolipoprotein E ε4 allele is not associated with early onset temporal lobe epilepsy, Neuroreport. 8 (1997), 1235-1237.
25. A. Gambardella, U. Aguglia, R. Cittadella, N. Romeo, G. Sibilia, E. LePiane, D. Messina, I. Manna, R.L. Oliveri, M. Zappia and A. Quattrone, Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy, Epilepsia. 40 (1999), 1804-1807.
26. A. Gambardella, U. Aguglia, R. Chifari, A. Labate, I. Manna, P. Serra, N. Romeo, G. Sibilia, E. Lepiane, A.L. Russa, P. Ventura, R. Cittadella, F. Sasanelli, E. Colosimo, U. Leggio, M. Zappia and A. Quattrone, ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy, Epilepsia. 46 (2005), 110-117.
27. J.P. Lagarde, P. Benlian, L. Zekraoui and A. Raisonnier, [Genotyping of apolipoprotein E (alleles epsilon 2, epsilon 3 and epsilon 4) from capillary blood], Ann Biol Clin (Paris). 53 (1995), 15-20.
28. P.R. Wenham, W.H. Price and G. Blandell, Apolipoprotein E genotyping by one-stage PCR, Lancet. 337 (1991), 1158-1159.
29. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNAfrom human nucleated cells, Nucleic Acids Res. 16 (1988), 1215.
30. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lipid Res. 31 (1990), 545-548.
31. S. Chhabra, D.P. Agarwal, S. Vasisht, K. Luthra, R. Narang, S.C. Manchanda, L.M. Srivastava and N. Das, Study of apolipoprotein E polymorphism in normal healthy controls from northern India, Dis Markers. 16 (2000), 159-161.
32. B.A. Kottke, P.P. Moll, V.V. Michels and W.H. Weidman, Levels of lipids, lipoproteins, and apolipoproteins in a defined population, Mayo Clin Proc. 66 (1991), 1198-1208.
33. D.S. Howland, S.P. Trusko, M.J. Savage, A.G. Reaume, D.M. Lang, J.D. Hirsch, N. Maeda, R. Siman, B.D. Greenberg, R.W. Scott and D.G. Flood, Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol, J Biol Chem. 273 (1998), 16576-16582.
34. A.R. Koudinov and N.V. Koudinova, Essential role for cholesterol in synaptic plasticity and neuronal degeneration, Faseb J. 15 (2001), 1858-1860.
35. D. Sporis, J. Sertic, N. Henigsberg, D. Mahovic, N. Bogdanovic and T. Babic, Association of refractory complex partial seizures with a polymorphism of ApoE genotype, J Cell Mol Med. 9 (2005), 698-703.
36. J.R. Lynch, D. Morgan, J. Mance, W.D. Matthew and D.T. Laskowitz, Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response, J Neuroimmunol. 114 (2001), 107-113.
37. D.T. Laskowitz, S. Goel, E.R. Bennett and W.D. Matthew, Apolipoprotein E suppresses glial cell secretion of TNF alpha, J Neuroimmunol. 76 (1997), 70-74.
38. D.T. Laskowitz, D.M. Lee, D. Schmechel and H.F. Staats, Altered immune responses in apolipoprotein E-deficient mice, J Lipid Res. 41 (2000), 613-620.
39. R.W. Mahley and Y. Huang, Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond, Curr Opin Lipidol. 10 (1999), 207-217.
40. F.J. Vajda, Neuroprotection and neurodegenerative disease, J Clin Neurosci. 9 (2002), 4-8.
41. K. Luthra, B. Bharghav, S. Chabbra, N. Das, A. Misra, D.P. Agarwal, R.M. Pandey and L.M. Srivastava, Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins, Mol Cell Biochem. 232 (2002), 97-102.
42. J. Poirier, Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease, Trends Neurosci. 17 (1994), 525-530.
43. F. Panza, V. Solfrizzi, A.M. Colacicco, A.M. Basile, A. D'Introno, C. Capurso, M. Sabba, S. Capurso and A. Capurso, Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians, Neuroreport. 14 (2003), 605-608.
44. I.A. Larson, J.M. Ordovas, C. DeLuca, J.R. Barnard, G. Feussner and E.J. Schaefer, Association of apolipoprotein (Apo)E genotype with plasma apo E levels, Atherosclerosis. 148 (2000), 327-335.
45. U.K. Misra, C.L. Adlakha, G. Gawdi, M.K. McMillian, S.V. Pizzo and D.T. Laskowitz, Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages, J Leukoc Biol. 70 (2001), 677-683.
46. J.R. Gee and J.N. Keller, Astrocytes: regulation of brain homeostasis via apolipoprotein E, Int J Biochem Cell Biol. 37 (2005), 1145-1150.
47. M. Aono, Y. Lee, E.R. Grant, R.A. Zivin, R.D. Pearlstein, D.S. Warner, E.R. Bennett and D.T. Laskowitz, Apolipoprotein E protects against NMDA excitotoxicity, Neurobiol Dis. 11 (2002), 214-220.
48. Y. Lee, M. Aono, D. Laskowitz, D.S. Warner and R.D. Pearlstein, Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity, Neurochem Int. 44 (2004), 107-118.
49. C.R. Gutman, W.J. Strittmatter, K.H. Weisgraber and W.D. Matthew, Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor, J Neurosci. 17 (1997), 6114-6121.